Production (Stage)
PharmaTher Holdings Ltd.
PHRM
CNSX
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.39% | -3.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.51% | 0.64% | |||
| Operating Income | -3.51% | -0.64% | |||
| Income Before Tax | 3.40% | 3.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.40% | 3.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.40% | 3.71% | |||
| EBIT | -3.51% | -0.64% | |||
| EBITDA | -3.56% | -0.60% | |||
| EPS Basic | 3.33% | 3.23% | |||
| Normalized Basic EPS | -5.88% | -6.25% | |||
| EPS Diluted | 3.33% | 3.23% | |||
| Normalized Diluted EPS | -5.88% | -6.25% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||